More glaucoma meds = more MG dropout.

A new study published in the Journal of Glaucoma found that as the number of glaucoma drops increased for a patient, so did their meibomian gland dropout.

Tell me about the study.
The study evaluated 115 patients, 85 of which were being treated for glaucoma. They established meibomian gland function via a series of testing (meibography, TBUT, Schirmer testing etc).
The authors found a significant correlation between meibomian gland loss and the number of glaucoma medications a patient was taking.

The take home: Patients taking multiple glaucoma drops are at risk for meibomian gland dropout and should be evaluated accordingly.

Get in Touch

LEAVE A REPLY

Please enter your comment!
Please enter your name here

For security, use of Google's reCAPTCHA service is required which is subject to the Google Privacy Policy and Terms of Use.

I agree to these terms.

Related Articles

Latest Posts